Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Adaptive Biotechnologies Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Recursion Pharmaceuticals Inc. June 18, 202594.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 6, 2026 | Recursion Pharmaceuticals Inc. | Option exercise | +25,000 | $2.22 | $55,500 |
| Oct 6, 2026 | Recursion Pharmaceuticals Inc. | Open-market sale | −25,000 | $5.00 | $125,000 |
| Aug 18, 2026 | Adaptive Biotechnologies Corporation | Option exercise | +15,000 | $6.32 | $94,800 |
| Aug 18, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −15,000 | $24.39 | $365,850 |
| Aug 18, 2026 | Adaptive Biotechnologies Corporation | Open-market sale | −15,664 | $24.41 | $382,358 |
| Jun 17, 2026 | Recursion Pharmaceuticals Inc. | Grant or award | +88,424 | — | — |
| Mar 4, 2026 | Adaptive Biotechnologies Corporation | Grant or award | +15,625 | — | — |
| Dec 10, 2025 | Adaptive Biotechnologies Corporation | Open-market sale | −22,968 | $16.00 | $367,488 |
| Jun 18, 2025 | Recursion Pharmaceuticals Inc. | Grant or award | +22,016 | — | — |
| Mar 12, 2025 | Adaptive Biotechnologies Corporation | Open-market sale | −53,000 | $7.59 | $402,270 |
| Mar 4, 2025 | Adaptive Biotechnologies Corporation | Grant or award | +15,394 | — | — |
| Jun 3, 2024 | Recursion Pharmaceuticals Inc. | Grant or award | +13,097 | — | — |
| Mar 4, 2024 | Adaptive Biotechnologies Corporation | Grant or award | +31,328 | — | — |
| Jun 16, 2023 | Recursion Pharmaceuticals Inc. | Grant or award | +12,612 | — | — |
| Mar 6, 2023 | Adaptive Biotechnologies Corporation | Grant or award | +14,775 | — | — |
Questions about Robert Hershberg
What boards is Robert Hershberg on?
Robert Hershberg sits on the boards of Adaptive Biotechnologies Corporation, Danaher Corporation, Fate Therapeutics Inc. and Recursion Pharmaceuticals Inc.
How long has Robert Hershberg served on boards?
Our records show at least 11 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.